Reporting nuchal translucency (NT) measurements of less than 1.0 mm are acceptable in the NHS Fetal Anomaly Screening Programme (FASP).
Joe has worked at the University of Plymouth in the medical statistics group since completing his bachelor’s degree in 2017. He has worked on the DQASS project since starting his current role as a research assistant and helps to produce the six monthly DQASS feedback reports.
Related content and links
The PHE Screening team
Public Health England (PHE) provides support and advice to the NHS-led national screening programmes. These programmes identify apparently healthy people who may be at increased risk of a disease or condition, enabling earlier treatment and informed decisions.
Find out more about PHE Screening and this blog.
Watch our 44 second video for an overview of how the blog works.